Akesobio prices Hong Kong IPO at top end

Pills_230px
By Jonathan Breen
20 Apr 2020

Akesobio has bagged HK$2.58bn ($332.9m) from its IPO after sealing the trade at the top of the marketed price range, according to a banker on the deal.

Sponsors JP Morgan and Morgan Stanley wrapped up the roadshow last Friday, having carried out a virtual bookbuilding for the deal amid the coronavirus-fueled restrictions on physical meetings.

The Chinese biopharmaceutical firm drew a horde of investors to its IPO, which comprised 159.5m shares. It offered the stock ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial